Shield acquires two UK laboratory companies:
This article was originally published in Clinica
Executive Summary
Scotland-based Shield Diagnostics has purchased two UK laboratory companies - Guardian Laboratories and Plasmatec Laboratory Products - for an initial price of £701,500 ($428,000) paid for in cash and shares. Following the acquisitions Shield merged the two companies. A deferred consideration will be payable depending on the profits of the new joint business to be conducted through Plasmatec. The two acquired companies are active in infectious disease.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.